Clover Health Investments (CLOV) Tops Q4 EPS by 24c

Clover Health Investments (NASDAQ: CLOV) reported Q4 revenue for the quarter at $898.79 million versus the consensus estimate of $785.48 million.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight